Recent biopharma seed and Series A funding rounds
| Company name | Funding type | Amount raised (USD) | Post-money valuation (USD) | Lead investor | Announcement date | Source |
|---|---|---|---|---|---|---|
| Solstice Oncology | Series A | $225,000,000.00 | $848,622,873.00 | RA Capital Management | 2026-09-09 | |
| Reju Therapeutics | Series A | – | $550,492,550.00 | – | 2026-10-21 | |
| Infinimmune | Series A | $75,000,000.00 | $347,529,635.00 | Playground Global, Regeneron Ventures | 2026-08-11 | |
| Afana Biotechnology | Series A | $50,000,000.00 | $283,376,129.00 | Anhui High-tech Industry Investment, Gaozheng Chuangtou, Hefei Industrial Investment Guozheng Equity Investment, Shenzhen Guozhong Venture Capital Management | 2026-11-06 | |
| Breye Therapeutics | Series A | $76,725,907.00 | $281,324,242.00 | Mission BioCapital, Novo Holdings | 2026-09-29 | |
| RegCell | Series A | $44,000,000.00 | $260,178,673.00 | Playground Global | 2026-09-15 | |
| Libo Biotech | Series A | $15,020,879.00 | $153,526,544.00 | Loyal Valley Capital, Sinovation Ventures | 2026-10-30 | |
| Cloverleaf Bio | Seed | $33,000,000.00 | $123,197,670.00 | 4BIO Capital | 2026-09-08 | |
| K2 Therapeutics | Seed | $50,000,000.00 | $184,856,339.00 | MPM Capital | 2026-08-11 | |
| BioStack | Seed | $9,500,000.00 | $41,830,752.00 | Afore Capital, DCVC, Emerson Collective, Peak XV Partners, Streamlined, SV Angel, Verdict Capital, Y Combinator | 2026-10-22 |